MondegarAI
…
← Tracker

Institutional

Artal Group S.A.

CIK 0001053906
$1.01B
Reported AUM
2
Positions
Q1 2026
Period
2026-05-14
Filed

The Brief · Artal Group S.A. · Q1 2026

AI · grounded in 13F

Artal Group S.A. increased its position in Lexicon Pharmaceuticals Inc LXRX by 13.62%. The fund added one new position to its portfolio. Total assets under management stood at $1.01B with two total positions.

Portfolio · Q1 2026

CAVA$769.2MLXRX$241.4MAS

Top holdings

QoQ vs Q4 2025

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1CAVACava Group Inc$72.601.18%-8.14%27.12%$769.2M76.11%—HELD
2LXRXLexicon Pharmaceuticals Inc$1.910.53%148.05%-46.05%$241.4M23.89%+18,553,846+13.6%

Source: SEC EDGAR · accession 0001053906-26-000006. 13F discloses long positions only — shorts, foreign equities, and options are excluded.